Related Experiment Video
Updated: Jul 10, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Immunizations for children with cancer
1Division of Infectious Diseases, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Ontario, Canada. upton.allen@sickkids.ca
Insights
Children with cancer face risks from infections. This review outlines key principles for safely and effectively vaccinating these vulnerable children, addressing data gaps.
Area of Science:
- Pediatric Oncology
- Immunology
- Infectious Diseases
Background:
- Children with malignant diseases are highly susceptible to severe outcomes from vaccine-preventable infections.
- Vaccinating immunocompromised children presents unique challenges regarding vaccine efficacy and safety.
- Current vaccination guidelines often rely on data from healthy populations and expert consensus due to limited specific research.
Purpose of the Study:
- To review the principles of vaccine use in pediatric cancer patients.
- To provide a framework for guiding vaccination decisions in children with malignant diseases.
- To address the paucity of data on vaccinating this specific population.
Main Methods:
- Literature review focusing on vaccine use in pediatric oncology.
- Synthesis of existing data and expert opinion on vaccine efficacy and safety in immunocompromised children.
- Identification of key principles for vaccination strategies.
Main Results:
- Vaccination is crucial for protecting children with cancer against preventable infections.
- Specific considerations regarding vaccine types, timing, and safety monitoring are necessary.
- A framework is proposed to guide clinical decision-making for vaccine administration.
Conclusions:
- Vaccination is a vital component of supportive care for children undergoing cancer treatment.
- Tailored vaccination strategies are essential to maximize protection while minimizing risks.
- Further research is needed to optimize vaccine protocols for pediatric cancer patients.
Abstract:
Children with malignant diseases are at risk of severe outcomes from vaccine preventable infections. Vaccination of these children presents challenges due to efficacy and safety concerns. There is a paucity of data on several aspects of vaccination in this group of children. Consequently, for the most part, data are extrapolated from healthy populations and combined with experts' opinions. This article reviews the use of vaccines in infants and children with cancer. In this context, an all-encompassing review is not the goal. Key principles are reviewed to provide a framework to guide the use of vaccines in children with malignant diseases.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Treatment Resistent Cancers